Vivani Medical, Inc. Gain (Loss) on Repurchase of Debt Instrument
Vivani Medical, Inc. (VANI) reported Gain (Loss) on Repurchase of Debt Instrument of $6.88 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnRepurchaseOfDebtInstrument · last filed 2023-03-31
- Vivani Medical, Inc. gain (loss) on repurchase of debt instrument for fiscal 2022 was $6.88M.
| Period end | Gain (Loss) on Repurchase of Debt Instrument 12 month |
|---|---|
| 2022-12-31 | $6.88M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |